Rozita Mohd - Concepedia

Author

Rozita Mohd

University Kebangsaan Malaysia Medical Centre ORCID

Also Known As

C Mohandas, M Rozita, M. ROZITA, M. Rozita, Mohd, Rozita, R Mohd, R. MOHD, R. Mohd, ROZITA MOHD, Rozita MOHD

103

Publications

963

Citations

H-Index

Concepts

All Affiliations

University Kebangsaan Malaysia Medical Centre National University of Malaysia Boehringer Ingelheim (Germany)Heidelberg University

About

Rozita Mohd is an author at University Kebangsaan Malaysia Medical Centre specializing in medicine, lupus, and systemic lupus erythematosus treatment.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	379
2	Public Health	4	4	149
3	Epidemiology	4	4	149
4	Diabetes	1	1	44
5	Family Medicine	1	1	19

Rozita Mohd

Publications

740

Citations

H-Index

Page 1

	Year	Citations
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial Katherine R. Tuttle, Sibylle J. Hauske, María Eugênia Fernandes Canziani, The Lancet HypertensionRenal FunctionRenal DiseaseMedicineKidney Failure	2023	151
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial PK Judge, Natalie Staplin, KJ Mayne, The Lancet Diabetes & Endocrinology	2023	88
Persistent hypertension in lupus nephritis and the associated risk factors S. S. Shaharir, Ruslinda Mustafar, Rozita Mohd, Clinical Rheumatology Glomerular DiseaseGlomerulonephritisHypertensionUrologyRenal Function	2014	60
Damage in the Multiethnic Malaysian Systemic Lupus Erythematosus (SLE) Cohort: Comparison with Other Cohorts Worldwide Syahrul Sazliyana Shaharir, Heselynn Hussein, Rajalingham Sakthiswary, PLoS ONE Systemic DiseasesPsoriatic ArthritisSle PatientsInflammatory ArthritisLogistic Analysis	2016	44
Role of febuxostat in retarding progression of diabetic kidney disease with asymptomatic hyperuricemia: a 6-months open-label, randomized controlled trial Mohd Noor Azreey Mukri, Wei Yen Kong, Ruslinda Mustafar, PubMed	2018	44
Immunoadsorption and plasmapheresis are equally efficacious as adjunctive therapies for severe lupus nephritis Chee-Yean Loo, Mohd Shahrir Mohamed Said, Rozita Mohd, Transfusion and Apheresis Science InflammationGlomerulonephritisAutoimmune DiseaseSystemic Lupus ErythematosusSystemic Lupus Erythematosus Treatment	2010	31
Assessment of body fluid status in hemodialysis patients using the body composition monitor measurement technique Rafidah Mamat, Norella Kong, Arbaiyah Bain, Journal of Clinical Nursing	2012	28
Risk factors for symptomatic Avascular Necrosis (AVN) in a multi-ethnic Systemic Lupus Erythematosus (SLE) cohort Syahrul Sazliyana Shaharir, Siew Huoy Chua, Rozita Mohd, PLoS ONE VasculitisOsteopathyLow DensityAvascular NecrosisOrthopaedic Surgery	2021	26
Gut microbiota in Immunoglobulin A Nephropathy: a Malaysian Perspective Agni Nhirmal Kumar Sugurmar, Rozita Mohd, Shamsul Azhar Shah, BMC Nephrology	2021	24
Intravenous calcitriol versus paricalcitol in haemodialysis patients with severe secondary hyperparathyroidism Abdul Halim Abdul Gafor, Rashidi Saidin, Rozita Mohd, Nephrology	2009	22

Page 1